ROC analyses of nine tumor markers (CEA, CA19–9, CYFRA, SCCA, AFP, PSA, CA125, CA15–3, and NCC-ST439) showed inadequate performance when used individually (Fig. 1). This evidence concerns the gene MUC16 and neoplasm.